Brahim Harbaoui
Brahim Harbaoui is an expert in Cardiology at Hospices Civils de Lyon (France). Brahim Harbaoui has authored 184 publications, the most recent in 2026, and is an investigator in 11 clinical trials, 5 of them ongoing. SLR score: 785 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Critical Care - Medical Imaging
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2013 - 2026
Number : 184
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 11
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| DAPAgliflozine to attenuate cardiac RemOdeling afTEr aCuTe myOcardial infarction 2024-511882-13-01 — myocardial infarction, heart failure, echocardiography, therapeutics | Phase 3 | Active not recruiting | 2024 |
| ATLANTIS Protamine Antagonization of heparin with protamine sulfate to reduce all neurologic ischemic and hemorrhagic events after transcatheter aortic valve implantation for aortic stenosis the ATLANTIS Protamine study 2023-504511-32-00 — protamines, constriction, pathologic, aortic valve stenosis, hospital mortality, insurance, heparin, aortic valve, transcatheter aortic valve replacement | Phase 3 | Recruiting | 2025 |
| Identifying Biological Markers of Cardiovascular Events in Patients With Aortic Stenosis or TAVI NCT06713889 — quality of life, constriction, pathologic, aortic valve stenosis, fibrosis, cardiology, biomarkers, aortic valve, transcatheter aortic valve replacement, edetic acid | N/A | Recruiting | 2024 |
| Modalities And Safety Of Cardiac Rehabilitation In A Population Managed For Spontaneous Hematoma Or Coronary Disruption NCT05744947 — safety, hematoma, cardiac rehabilitation, data collection, rehabilitation, arteries, dissection | N/A | Recruiting | 2023 |
| Cohort of STEMI Patients 2 NCT05794022 — injections, quality of life, blood, myocardial infarction, biomarkers, st elevation myocardial infarction, research | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map